Pharmaceutical - Sustainability Next

Home Pharmaceutical

ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
Business Wire India ITM gains exclusive global development and commercialization rights to Debiopharm’s first-in-class, peptide-based theranostic pair which combines therapeutic compound, Debio 0228 ([177Lu]Lu-DPI-4452) and diagnostic imaging agent, Debio 0328 ([68Ga]Ga-DPI-4452) to target Carbonic Anhydrase IX (CA IX) Debiopharm to receive upfront, development and regulatory milestone payments of approximately €300 million, as well as commercial […]
MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors
Business Wire IndiaMRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today announced the appointment of Grégoire Franoux, M.B.A., to the newly created role of Chief Business Officer. Concurrently, the company has strengthened its Board of Directors with the appointment of industry veteran Ron Robison, M.D. “We […]